NMI-8000

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameNMI-8000
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionAnti-Mullerian hormone receptor modulators
TargetsAnti-Mullerian hormone receptor
Therapy Area/IndicationsGenital Neoplasms, FemaleOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMassachusetts General HospitalNemucore Medical Innovations
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNemucore Medical InnovationsPfenex Biopharmaceuticals IncMassachusetts General Hospital
Active IndicationsN/A
Inactive IndicationsGenital Neoplasms, FemaleOvarian Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A